U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208411

Expand all

NARCAN (NALOXONE HYDROCHLORIDE)
4MG/SPRAY
Marketing Status: Prescription
Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: NARCAN
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 4MG/SPRAY
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N208411
Product Number: 001
Approval Date: Nov 18, 2015
Applicant Holder Full Name: EMERGENT OPERATIONS IRELAND LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
NARCAN (NALOXONE HYDROCHLORIDE)
2MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: NARCAN
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 2MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N208411
Product Number: 002
Approval Date: Jan 24, 2017
Applicant Holder Full Name: EMERGENT OPERATIONS IRELAND LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top